Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaudhry, V.
Right arrow Articles by Drachman, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaudhry, V.
Right arrow Articles by Drachman, D. B.
Related Collections
Right arrow All Neuromuscular Disease
Right arrow Myasthenia
Right arrow Peripheral neuropathy
Right arrow Muscle disease
Right arrow All Clinical trials
Right arrow Clinical trials Observational study (Cohort, Case control)

Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases

V. Chaudhry, MD;, D. R. Cornblath, MD;, J. W. Griffin, MD;, R. O’Brien, MD, PhD; and D. B. Drachman, MD

From the Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.



View larger version (22K):

[in a new window]
  		Figure. (A) Functional grade before and after mycophenolate mofetil (MM) treatment in the 32 patients with MG. The solid line in the middle (connecting two solid circles) is the mean functional grade before (2.2) and after MM (1.2). The change was significant (p < 0.001). (B) The requirement of corticosteroids before and after MM treatment in the 32 patients with MG. The mean dose of steroids (shown by the solid line connected two solid circles) before was 50 mg and after treatment was 27 mg every other day. These changes were also significant (p = 0.001) .

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.